An Anti-Inflammatory Sterol Decreases Obesity-Related Inflammation-Induced Insulin Resistance and Metabolic Dysregulation

Figure 2

Coefficients of variation for individual subject hematology and chemistry values in placebo comparisons. DL: dyslipidemic placebo group, IGT: impaired glucose tolerant placebo group, Naïve: treatment-naïve uncontrolled T2DM placebo group, MET: uncontrolled T2DM placebo group on a stable dose of metformin, Hb: hemoglobin, Hct: hematocrit, RBC: red blood cell count, MCV: mean cell volume, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin concentration, HbA1c: hemoglobin A1c, HDL: high density lipoprotein cholesterol, LDL: low density lipoprotein cholesterol. ^#Statistically significant (Welch ANOVA, allowing unequal variance) increase in mean coefficient of variation compared to healthy participants. *Statistically significant dispersion (2-sided 𝐹 test) in the coefficient of variation compared to healthy participants.